Abstract
Abstract ID: 62 Dupilumab Efficacy and Safety up to 52 Weeks in Adult and Adolescent Patients With Eosinophilic Esophagitis: Results From Parts B and C of the Randomized, Placebo-Controlled, Three-Part, Phase 3 LIBERTY EoE TREET Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Foregut: The Journal of the American Foregut Society
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
